ArticleInvestigative ophthalmology & visual science2025
Lens Thickness-to-Anterior Chamber Depth Ratio: A Biometric Determinant of Chamber Angle Width in Han Chinese Cataract Patients.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Distribution characteristics and influencing factors of three-dimensional lens parameters in patients with age-related cataracts.BMC ophthalmology · 2026Article
- Association of ocular biometrics with clinical severity in acute angle-closure glaucoma with cataract: a retrospective study.American journal of translational research · 2026Article
- Association Between Lens Thickness and SRK/T Refractive Prediction Error After Cataract Surgery: A Single-Center Retrospective Cohort Study.Journal of ophthalmology · 2026Article
- Axial Length Profiles in Inherited Retinal Diseases-A Genotypic and Phenotypic Analysis.Investigative ophthalmology & visual science · 2025Article
- Distribution patterns and determinants of the lens thickness-to-anterior chamber depth ratio in cataract patients.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to individuate a novel ocular biometric index, the lens thickness-to-anterior chamber depth (LT/ACD) ratio, and identify its role in explaining anterior chamber angle width (ACAW) in Han Chinese patients with cataract. Methods: We enrolled 400 patients with cataract with phakic eyes. According to the axial length (AL), the eyes were divided into short eyes (AL < 22 mm, n = 100), medium eyes (22 ≤ AL < 24 mm, n = 100), medium‒long eyes (24 ≤ AL < 26 mm, n = 100), and long eyes (AL ≥ 26 mm, n = 100). We used a Pentacam HR to determine ACAW and an IOLMaster 700 to measure ACD and LT. A narrow chamber angle was defined as an ACAW < 20 degrees. Results: Using a multivariable linear model, which included the LT/ACD ratio, age, sex, AL, white-to-white, keratometry, central corneal thickness, and pupil diameter, the LT/ACD ratio was the strongest determinant of ACAW in the total group (standardized regression coefficient [β] = -0.71), short eyes (β = -0.71), medium eyes (β = -0.69), medium-long eyes (β = -0.72), and long eyes (β = -0.63). The LT/ACD ratio remained the strongest determinant of ACAW in eyes with an ACD < 3.0 mm (β = -0.51) or an LT ≥ 5.0 mm (β = -0.64). Multivariable logistic analysis revealed a significant association between a greater LT/ACD ratio and the presence of angle narrowness in the total group (odds ratio = 156.7, 95% confidence interval [CI] = 10.8-2270.4). An LT/ACD ratio of 1.8 could indicate angle narrowness (area under the curve = 0.94). Conclusions: In Han Chinese patients with cataract, the LT/ACD ratio can be used as an ocular biometric determinant of ACAW. An LT/ACD ratio exceeding 1.8 could effectively identify the presence of angle narrowness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.